# Multifunctional Skin Dermal Extracellular Matrix Enabling Skin-Relevant Bioactivity for Tissue Remodeling, Hydration, and Anti-Hyperpigmentation

**Authors:** Yu Heun Kim, Sewon Park, Jung Ho Cho, Seung Yeop Han, Seung-Woo Cho

PMC · DOI: 10.4014/jmb.2601.01001 · 2026-01-13

## TL;DR

This study shows that decellularized skin-derived ECM can improve skin aging by enhancing elasticity, hydration, and reducing pigmentation.

## Contribution

The novelty lies in demonstrating the multifunctional bioactivity of decellularized skin ECM for cosmetic use.

## Key findings

- Skin ECM upregulates genes involved in ECM remodeling and hydration in human fibroblasts.
- Skin ECM enhances fibroblast metabolic activity more than other tested ingredients.
- Skin ECM reduces melanin accumulation in melanoma cells under specific conditions.

## Abstract

Dermal extracellular matrix (ECM) deterioration is a central driver of skin aging, contributing to impaired elasticity, decreased moisturization, and uneven pigmentation. However, commonly used single-component ingredients and cell-derived bioactives provide limited coordinated cues and may therefore be insufficient to address these multifactorial processes. Here, we propose decellularized skin-derived ECM (skin ECM) as a multifunctional cosmetic ingredient through comparison with various existing cosmetic ingredients. Proteomic analysis shows that skin ECM retains diverse collagen subtypes along with glycoproteins and proteoglycans associated with dermal tensile properties and matrix regulation, more closely reflecting native dermal matrisome diversity than commercial collagen products. Skin ECM at an optimal concentration most effectively upregulates the expression of genes involved in ECM remodeling and hyaluronan-mediated hydration in human dermal fibroblasts. In comparative supplementation assay, skin ECM enhances fibroblast metabolic activity and induces the strongest expression of key ECM- and hydration-related genes among all tested ingredients. Interestingly, skin ECM reduces the expression of melanogenesis-related markers and melanin accumulation in melanoma cells under experimental conditions with α-melanocyte stimulating hormone treatment. Collectively, these findings highlight the potential of skin ECM for cosmetic applications to improve overall skin conditioning and its broader promise for anti-skin aging.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** DPT (dermatopontin) [NCBI Gene 1805] {aka TRAMP}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, Dct (dopachrome tautomerase) [NCBI Gene 13190] {aka DT, TRP-2, TRP2, Tyrp-2, Tyrp2, slaty}, LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}, PCOLCE (procollagen C-endopeptidase enhancer) [NCBI Gene 5118] {aka PCPE, PCPE-1, PCPE1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}, HAS1 (hyaluronan synthase 1) [NCBI Gene 3036] {aka HAS}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, FBLN5 (fibulin 5) [NCBI Gene 10516] {aka ADCL2, ARCL1A, ARMD3, CMT1H, DANCE, EVEC}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, OGN (osteoglycin) [NCBI Gene 4969] {aka OG, OIF, SLRR3A}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, ASPN (asporin) [NCBI Gene 54829] {aka OS3, PLAP-1, PLAP1, SLRR1C}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, Tyrp1 (tyrosinase-related protein 1) [NCBI Gene 22178] {aka Oca3, TRP-1, TRP1, Tyrp, b, brown}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, HAS2 (hyaluronan synthase 2) [NCBI Gene 3037], FBN1 (fibrillin 1) [NCBI Gene 2200] {aka ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFLS}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}
- **Diseases:** hyperpigmentation (MESH:D017495), pigmentation (MESH:D010859), melanoma (MESH:D008545), toxicity (MESH:D064420), hypopigmentation (MESH:D017496)
- **Chemicals:** CO2 (MESH:D002245), hyaluronan (MESH:D006820), DTT (MESH:D004229), SYBR Green (MESH:C098022), VEA (MESH:D024502), Water (MESH:D014867), butylene glycol (MESH:C028491), NMN (MESH:D009537), penicillin (MESH:D010406), streptomycin (MESH:D013307), ethanol (MESH:D000431), DMSO (MESH:D004121), tetrazolium (MESH:D013778), urea (MESH:D014508), DMEM (-), methionine (MESH:D008715), retinoids (MESH:D012176), Melanin (MESH:D008543), acetonitrile (MESH:C032159), S (MESH:D013455), P (MESH:D010758), IAA (MESH:D007460), eumelanin (MESH:C041877), ammonium bicarbonate (MESH:C027043), phenol red (MESH:D010637), NaOH (MESH:D012972), GlutaMAX (MESH:C054122), glucose (MESH:D005947), formic acid (MESH:C030544), retinyl palmitate (MESH:C014794), PDRN (MESH:D011089), EAA (MESH:C000594008)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Centella asiatica (Asiatic pennywort, species) [taxon 48106]
- **Cell lines:** B16F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12828126/full.md

---
Source: https://tomesphere.com/paper/PMC12828126